<DOC>
	<DOCNO>NCT02153996</DOCNO>
	<brief_summary>Plasmodium falciparum malaria major cause morbidity mortality tropical sub-tropical area worldwide . Repeated P. falciparum infection endemic area induce protective immunity , thus provide optimism effective malaria vaccine develop . Key development vaccine understand immune mechanism underlie protection longevity responses absence continuous P. falciparum exposure . Anecdotal evidence suggest clinical immunity malaria wane within month year immune individual leaf endemic area . A detailed , systematic description quality longevity P. falciparum-specific humoral cellular immune response individual time absence ongoing exposure lack . This protocol attempt fill knowledge gap comprehensive longitudinal immunological analysis two population healthy adult volunteer : 1 ) naive traveler return malaria endemic area recently treat ( within 2 week ) acute P. falciparum malaria refer hospital metropolitan Washington DC area ; 2 ) immigrant malaria endemic area live metropolitan Washington DC area serologic evidence past P. falciparum exposure . In group , venipuncture possibly apheresis perform isolation plasma , RNA peripheral blood mononuclear cell ( PBMCs ) analyse understand component innate adaptive immunity malaria . Na ( SqrRoot ) traveler return malaria endemic area recently treat acute malaria undergo venipuncture enrollment , every 2 week 2 month , every 3 month 1 year , every 6 month 5 year . Immigrants see every three month one year every six month 5 year . All subject return U.S. malaria endemic area evaluate within two week return repeat venipuncture restart sequence blood draw naive traveler . Optional apheresis perform na ( SqrRoot ) travelers immigrant enrollment , 1 , 6 , 12 month , yearly therafter . The primary objective estimate quality longevity P. falciparum-specific humoral cellular immune response absence ongoing P. falciparum exposure return na ( SqrRoot ) travelers immigrant . The secondary objective compare P. falciparum-specific humoral cellular immune response na ( SqrRoot ) travelers immigrants individual malaria-endemic area enrol ongoing LIG protocol Mali .</brief_summary>
	<brief_title>Longitudinal Analysis Plasmodium Falciparum-Specific Immunity Travelers Immigrants From Malaria Endemic Areas United States</brief_title>
	<detailed_description>Plasmodium falciparum malaria major cause morbidity mortality tropical sub-tropical area worldwide . Repeated P. falciparum infection endemic area induce protective immunity , thus provide optimism effective malaria vaccine develop . Key development vaccine understand immune mechanism underlie protection longevity responses absence continuous P. falciparum exposure . Anecdotal evidence suggest clinical immunity malaria wane within month year immune individual leaf endemic area . A detailed , systematic description quality longevity P. falciparum-specific humoral cellular immune response individual time absence ongoing exposure lack . This protocol attempt fill knowledge gap comprehensive longitudinal immunological analysis two population healthy adult volunteer : 1 ) naive traveler return malaria endemic area recently treat ( within 2 week ) acute P. falciparum malaria refer hospital metropolitan Washington DC area ; 2 ) immigrant malaria endemic area live metropolitan Washington DC area serologic evidence past P. falciparum exposure . In group , venipuncture possibly apheresis perform isolation plasma , RNA peripheral blood mononuclear cell ( PBMCs ) analyse understand component innate adaptive immunity malaria . Na ( SqrRoot ) traveler return malaria endemic area recently treat acute malaria undergo venipuncture enrollment , every 2 week 2 month , every 3 month 1 year , every 6 month 5 year . Immigrants see every three month one year every six month 5 year . All subject return U.S. malaria endemic area evaluate within two week return repeat venipuncture restart sequence blood draw naive traveler . Optional apheresis perform na ( SqrRoot ) travelers immigrant enrollment , 1 , 6 , 12 month , yearly therafter . The primary objective estimate quality longevity P. falciparum-specific humoral cellular immune response absence ongoing P. falciparum exposure return na ( SqrRoot ) travelers immigrant . The secondary objective compare P. falciparum-specific humoral cellular immune response na ( SqrRoot ) travelers immigrants individual malaria-endemic area enrol ongoing LIG protocol Mali .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>INCLUSION CRITERIA : All Subjects : Age 1865 Agree blood specimen store future research genetic study Malaria endemicity define accord CDC Yellow Book criterion available : http : //wwwnc.cdc.gov/travel/yellowbook/2014/chapter3infectiousdiseasesrelatedtotravel/malaria # 3929 NaIve traveler return malaria endemic area recently treat malaria : Treated acute P. falciparum malaria within 4 week enrol study determine clinical microbiologic evidence ( include blood smear ) infection indicate medical record Immigrants malaria endemic area : Confirmation live malaria endemic area documentation verifiable detailed immigration history . Evidence past P. falciparum exposure positive AMA 1 ELISA . SUBJECT EXCLUSION CRITERIA : History HIV and/or hepatitis C. Inadequate peripheral venous access Current use steroid equivalent prednisone 20mg/day systemic immunosuppressant Underlying heart disease , lung disease , bleed disorder , condition , judgment investigator , contraindicate study participation Temperature great equal 37.5 ( Infinite ) C clinical evidence acute infection Currently pregnant ( positive urine betaHCG ) breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 15, 2016</verification_date>
	<keyword>Malaria Immunity Longevity</keyword>
</DOC>